We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$2.21B
AUM Growth
+$402M
(+22%)
Cap. Flow
+$267M
Cap. Flow
% of AUM
12.07%
Top 10 Holdings %
Top 10 Hldgs %
16.09%
Holding
1,247
New
172
Increased
894
Reduced
64
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.97M |
| 2 |
Apple
AAPL
|
+$8.92M |
| 3 |
Amazon
AMZN
|
+$8.89M |
| 4 |
Broadcom
AVGO
|
+$8.06M |
| 5 |
BF
BASF AKTIENGESELLT ADS(RP1 ORD
BF
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$3.45M |
| 2 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$3.39M |
| 3 |
MSCI
MSCI
|
+$3.27M |
| 4 |
Broadridge
BR
|
+$3.02M |
| 5 |
MON
Monsanto Co
MON
|
+$2.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 12.6% |
| 3 | Healthcare | 11.99% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DNB
401
DELISTED
Dun & Bradstreet
DNB
| $1.44M | 0.07% |
11,733
+1,709
| +17% | +$208K |
|
|
MASI
402
DELISTED
Masimo
MASI
| $1.44M | 0.07% |
14,723
+1,578
| +12% | +$150K |
|
403
Texas Capital Bancshares
TCBI
$4.31B
| $1.44M | 0.07% |
15,712
+2,256
| +17% | +$219K |
|
404
Integra LifeSciences
IART
$1.54B
| $1.44M | 0.07% |
+22,313
| New | +$1.38M |
|
405
Johnson Controls International
JCI
$87.5B
| $1.44M | 0.07% |
+42,953
| New | +$1.49M |
|
406
First Industrial Realty Trust
FR
$8.88B
| $1.44M | 0.07% |
43,072
+10,715
| +33% | +$338K |
|
407
Interactive Brokers
IBKR
$40.9B
| $1.43M | 0.06% |
88,864
+9,520
| +12% | +$172K |
|
408
Cintas
CTAS
$82.4B
| $1.43M | 0.06% |
30,884
+7,368
| +31% | +$332K |
|
409
Sempra
SRE
$60.8B
| $1.43M | 0.06% |
24,622
+5,238
| +27% | +$286K |
|
410
Kirby Corp
KEX
$7.95B
| $1.42M | 0.06% |
16,996
+2,436
| +17% | +$211K |
|
411
Pediatrix Medical
MD
$2.16B
| $1.42M | 0.06% |
32,768
+4,953
| +18% | +$237K |
|
412
ICU Medical
ICUI
$3.93B
| $1.42M | 0.06% |
4,821
+614
| +15% | +$168K |
|
413
Roper Technologies
ROP
$36.3B
| $1.41M | 0.06% |
5,116
+1,260
| +33% | +$348K |
|
|
CTXS
414
DELISTED
Citrix Systems Inc
CTXS
| $1.41M | 0.06% |
13,431
-1,279
| -9% | -$132K |
|
415
Pinnacle Financial Partners Inc
PNFP
$15.5B
| $1.41M | 0.06% |
22,932
+2,454
| +12% | +$159K |
|
|
NATI
416
DELISTED
National Instruments Corp
NATI
| $1.4M | 0.06% |
33,347
+3,571
| +12% | +$158K |
|
417
nVent Electric
NVT
$24.5B
| $1.4M | 0.06% |
+55,744
| New | +$1.45M |
|
418
Best Buy
BBY
$18B
| $1.4M | 0.06% |
18,742
+4,275
| +30% | +$316K |
|
|
CA
419
DELISTED
CA, Inc.
CA
| $1.4M | 0.06% |
39,211
+9,102
| +30% | +$321K |
|
420
Newmont
NEM
$98.2B
| $1.38M | 0.06% |
36,556
-2,647
| -7% | -$104K |
|
421
Emcor
EME
$33.1B
| $1.38M | 0.06% |
18,091
+1,936
| +12% | +$150K |
|
422
LivaNova
LIVN
$4.3B
| $1.38M | 0.06% |
+13,792
| New | +$1.25M |
|
423
Nu Skin
NUS
$247M
| $1.38M | 0.06% |
17,594
+3,194
| +22% | +$247K |
|
424
Weyerhaeuser
WY
$17.3B
| $1.38M | 0.06% |
37,741
+8,878
| +31% | +$325K |
|
425
FNB Corp
FNB
$6.78B
| $1.38M | 0.06% |
102,445
+15,215
| +17% | +$205K |
|
Similar funds
SAM
Pacer Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Pacer Advisors held 1,247 positions worth $2.21B, up 22% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Pacer Advisors deployed $267M of net new capital in Q2 2018, opening 172 new positions and adding to 894 existing holdings. Its largest new stake was Broadcom: 328,700 shares worth $7.98M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Abiomed Inc, an estimated $3.45M trimmed.
- Pacer Advisors's largest Q2 2018 buy was Broadcom: 328,700 shares worth $7.98M.
- Pacer Advisors added most to Microsoft in Q2 2018, an estimated $8.97M increase.
- Pacer Advisors's biggest Q2 2018 reduction was Abiomed Inc, cutting an estimated $3.45M.
- Pacer Advisors fully exited Royal Dutch Shell PLC ADS Class B in Q2 2018, selling an estimated $3.39M.
- Pacer Advisors's ten largest holdings make up 16% of its $2.21B portfolio in Q2 2018.
- Pacer Advisors opened 172 new positions and closed 79 in Q2 2018.
- Pacer Advisors's portfolio value rose 22% quarter-over-quarter to $2.21B.
Based on Pacer Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.